News

You might think UnitedHealth Group Inc. (UNH) would be on the ropes. One of its top executives was shot dead, its CEO resigned for personal reasons and the federal government is probing its billing ...
UnitedHealth Group's string of bad news goes back to early 2024. Many of the issues the healthcare giant faces should be only temporary. The stock's low valuation could present an opportunity for ...
A longtime investors' favorite. UnitedHealth Group (NYSE: UNH) is all those things. However, it's also now a big loser. Shares of UnitedHealth Group have plunged more than 50% below the peak ...
Investing.com -- AM Best, a renowned credit rating agency, has revised the outlook for UnitedHealth Group Incorporated (NYSE:UNH) and its subsidiaries from stable to negative. Despite this ...
The core operations of UnitedHealth Group Inc. (NYSE:UNH) provide insurance plans to individuals, companies, and government programs such as Medicare. Its second division, Optum, offers direct ...
The Wall Street Journal reports the DOJ is investigating UnitedHealth Group for possible Medicare fraud. UnitedHealth Group's stock tumbled again on Thursday amid the report. Since last month ...
Shares of UnitedHealth Group plunged more than 13% on Thursday following a report that the Department of Justice is conducting a criminal investigation into the health-care giant over possible ...
UnitedHealth Group is being investigated for possible Medicare fraud, according to The Wall Street Journal, sending shares of the healthcare company sliding in after-hours trading just one day ...
Grab the top 3 stocks to buy right here. UnitedHealth Group, Inc. UNH has fallen nearly 50% over the past month, fueled by a series of negative catalysts. Several analysts have slashed price ...
UnitedHealth Group, a key Dow-30 index company with a market capitalization of $284 billion, is down 38% year to date and by a similar margin over the last one year. (Shutterstock) UnitedHealth ...
UnitedHealth Group's CEO Andrew Witty resigned due to personal reasons amidst financial challenges, prompting Stephen Hemsley to return as CEO. The company withdrew its 2025 financial outlook ...